Results 241 to 250 of about 110,777 (250)

The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace

Journal of Infectious Diseases, 2017
Latania K Logan, Robert A Weinstein
exaly  

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

Lancet Infectious Diseases, The, 2018
Mical Paul, George L Daikos, Emanuele Durante Mangoni   +2 more
exaly  

Nationwide Surveillance of Clinical Carbapenem-resistant Enterobacteriaceae (CRE) Strains in China

EBioMedicine, 2017
Rong Zhang, Yi Li, Kang Liao
exaly  

Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii

Drug Resistance Updates, 2012
Nabil Karah, Arnfinn Sundsfjord, Ørjan Samuelsen   +2 more
exaly  

Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria

Clinical Infectious Diseases, 2019
Patrice Nordmann, Laurent Poirel
exaly  

Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections

Clinical Infectious Diseases, 2019
Yohei Doi
exaly  

Carbapenem Resistance: A Review

Medical Sciences (Basel, Switzerland), 2018
Eric S Donkor
exaly  

Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections: Table 1.

Clinical Infectious Diseases, 2016
Ryan K Shields, Ghady Haidar, Yohei Doi
exaly  

Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia

Antimicrobial Agents and Chemotherapy, 2017
Ryan K Shields, M Hong Nguyen, Liang Chen   +2 more
exaly  

Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology

Clinical Microbiology and Infection, 2006
exaly